4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-046247
President & CIO sold 26,831 shares at $23.09 ($619,528)
- President & CIO disposed of 32,682 shares (other)
- President & CIO acquired 59,513 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sukhatme Mayukh President & CIO | 2025-12-17 | Option exercise | +59,513 | $12.68 | $754,625 | 18,896,060 | D |
| Sukhatme Mayukh President & CIO | 2025-12-17 | Sale | −26,831 | $23.09 | $619,528 | 18,869,229 | D |
| Sukhatme Mayukh President & CIO | 2025-12-17 | Other disposition | −32,682 | $23.09 | $754,627 | 18,836,547 | D |
| Derivatives | |||||||
| Sukhatme Mayukh President & CIO | 2025-12-17 | Option exercise · Common Shares | −59,513 | 1,304,198 | D | ||
| Open-market sales · 26,831 sh · avg $23.09 · $619,528 | |||||||
Loading xslF345X05/form4.xml…